Assessing Clinical and Economic Value

PMC studies the clinical and economic value of personalized health care approaches across a broad range of disease states.


“Cost-Effectiveness of Exome and Genome Sequencing for Children With Rare and Undiagnosed Conditions,” Genetics in Medicine


"Clinical and Economic Value of Genetic Sequencing for Personalized Therapy in Non-small-cell Lung Cancer," Clinical Lung Cancer


"Cost Effectiveness of Multigene Panel Sequencing for Patients
With Advanced Non–Small-Cell
Lung Cancer," JCO Clinical
Cancer Informatics

"One Size Does Not Always Fit All in Value Assessment," American Journal of Managed Care


Personalized Medicine and Value Assessment Frameworks: Context, Considerations, and Next Steps

Research Lead

Daryl Pritchard, Ph.D., Senior Vice President, Science Policy

Research Assistant

Lindsay Stephens, Senior Operations Manager and Secretary to the Board